Seeking Alpha

Chipotle (CMG +0.8%) stands to benefit if the FDA begins to intensify regulations over the use...

Chipotle (CMG +0.8%) stands to benefit if the FDA begins to intensify regulations over the use of antibiotics in animal feed, according to some analysis on CMG that doesn't involve momentum trading. The company claims natural ingredients in its products, which could put in a position to market itself against other casual dining names at risk of getting mixed into an expanded FDA inquiry.
Comments (4)
  • Whatever the hell a "natural" ingredient is...
    15 May 2012, 12:01 PM Reply Like
  • If everybody is providing food with no antibiotics, CMG will no longer enjoy an advantage it has over competition. It will lose an edge. Why is this new regulation a benefit for CMG?? Chipotle will be the next Crocs, Netflix, and Green Mountain...

     

    http://bit.ly/K2J9Dh

     

    http://bit.ly/J023JT
    15 May 2012, 01:01 PM Reply Like
  • It will work in reverse. If other companies show comparable product testing results, CMG will be in a more competitive environment
    15 May 2012, 01:43 PM Reply Like
  • Who can trust anything CMG says? That is why the SEC has joined the long running illegal immigrant hiring probe of CMG's top management. I don't see how FMR and the many institutional holders of this stock can continue to support it with so many questions surrounding the lack of a stock with integrity.
    19 May 2012, 07:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)